Exercise-induced cardiac remodeling (EICR) and the attendant myocardial adaptations 49 characteristic of the athlete's heart may regress during periods of exercise reduction or 50 abstinence. The time course and mechanisms underlying this reverse remodeling, 51 specifically the impact of concomitant plasma volume (PV) contraction on cardiac 52 chamber size, remain incompletely understood. We therefore studied recreational runners 53 (n=21, aged 34 ± 7 years; 48% male) who completed an 18-week training program (~7 54 h w -1 ) culminating in the 2016 Boston Marathon after which total exercise exposure was 55 confined to <2 h.w -1 (no single session >1 hour) for 8 weeks. Cardiac structure and 56 function, exercise capacity, and PV were assessed at peak fitness (10-14 days before) and 57 at 4-and 8-weeks post marathon. Mixed linear modeling adjusting for age, sex, V̇O 2peak 58 and marathon finish time was used to compare data across time points. Physiologic 59 detraining was evidenced by serial reductions in treadmill performance. Two distinct 60 phases of myocardial remodeling and hematologic adaptation were observed. After 4 61 weeks of detraining, there were significant reductions in PV (Δ -6.0%, P<0.01), left 62 ventricular (LV) wall thickness (Δ -8.1%, <0.05), LV mass (Δ -10.3%, P<0.001), and 63 right atrial area (Δ -8.2%, P<0.001). After 8 weeks of detraining, there was a significant 64 reduction in right ventricle chamber size (end-diastolic area Δ = -8.0%, P <0.05) without 65 further concomitant reductions in PV or LV wall thickness. Abrupt reductions in exercise 66 training stimulus result in a structure-specific time course of reverse cardiac remodeling 67 that occurs largely independently of PV contraction. 68 Key Words: sports cardiology, left ventricle, cardiac morphology, echocardiography, 69 hemoglobin mass 70 71
ABSTRACT (246 words)
Routine vigorous endurance exercise stimulates numerous changes in 100 cardiovascular structure and function and concomitant increases in blood volume (BV) . 101
Specifically, the process of exercise induced cardiac remodeling (EICR) is characterized 102 by mild to moderate biventricular eccentric hypertrophy, preserved or enhanced diastolic 103 function, bi-atrial dilation, and BV expansion. EICR has been thoroughly characterized 104 among elite athletes (2, 11, 18, 19, 21, 33) and has recently been documented among 105 recreational exercisers who typically perform comparatively lower volumes and 106 intensities of exercise training (1, 8, 13, 28, 35) . Similarly, the hematologic response to 107 endurance exercise training has been described in novice exercisers where a rapid 108 increase in plasma volume (PV) precedes a slow increase in red blood cell volume (16) . 109
A recent meta-analysis concluded that increases in red blood cell volume of 4% can be 110 expected over 15 weeks of endurance training in young and middle aged exercisers (16) . 111
While several studies document reductions in left ventricular (LV) wall thickness 112 and chamber size following periods of exercise abstinence among elite competitive 113 athletes (15, 20, 34) , and during periods of bed rest in non-athletes (9), the reversibility of 114 EICR among recreational athletes has not been described. In addition, no prior studies 115 have described the change in blood volume that occur during exercise detraining in this 116 population. Consequently, several key issues pertaining to EICR regression including the 117 time course, the mechanistic role of blood volume contraction, and the response of 118 cardiac chambers other than the left ventricle remain incompletely understood. 119
We therefore studied cardiac structure, function and blood volume components 120 among recreational marathon runners who participated in an 8-week prescribed exercise 121 detraining program following completion of a marathon race (42.2 km). We hypothesized 122 that participants would demonstrate significant reverse cardiac remodeling characterized 123 by reductions in chamber volumes and wall thickness and that this reverse remodeling 124 would parallel and perhaps be mechanistically driven by reductions in blood volume. 125 126 METHODS 127
Study Design Overview 128
We used a prospective, longitudinal, and repeated measures study design to 129 examine the cardiovascular response to prescribed detraining among healthy recreational 130 marathon runners participating in the 2016 Boston Athletic Association's Boston 131
Marathon (42 km foot race). An initial sample of 24 runners (50% men) were recruited 132 and consented to this study. No participants had established cardiovascular disease at the 133 time of enrollment and all were free of inducible myocardial ischemia and arrhythmia 134 during baseline cardiopulmonary exercise testing. Five female participants were routinely 135 taking oral contraceptive pills. Otherwise, no participants started or stopped any 136 prescription or over-the-counter medications during the study period. In preparation for 137 the marathon, participants completed a standardized running training program that has 138 previously been shown to be an adequate exercise dose to stimulate exercise-induced 139 cardiac remodeling (35), and all participants completed the marathon without medical 140 complications. Following the marathon, participants were instructed to restrict their 141 exercise dose to < 2 hours/week of low intensity exercise, with no single exercise session 142 > 1 hour in duration and no interval training of any kind. 143
Participants underwent study measurements at 3 time points: peak fitness at 1-2 144 weeks prior to the marathon, 4-weeks post-race, and 8-weeks post-race (Figure 1) . 145
Assessment at each study time point included measurement of height, weight, fasting 146 blood sampling, cardiac structure and function using transthoracic echocardiography, 147 maximal exercise capacity using cardiopulmonary exercise testing, and hematologic 148 parameters using carbon monoxide rebreathing as described in detail below. The study 149 was approved by the Partners Healthcare System Human Research Committee, and 150 written informed consent was obtained from each participant at the time of enrollment. 151 152 Exercise exposure during the study period 153
Self-reported exercise participation data were gathered on a weekly basis during 154 the study period using a written questionnaire. Running distance and duration, aerobic 155 cross training, and any other deliberate exercise training sessions were collected. Exercise 156 exposure was categorized into running (total mileage; figure 2, panel A) and durations 157 of: 1.) Running, 2.) Cross-training (including outdoor cycling, stationary cycling, 158 elliptical trainer, skiing, zumba, and team sports such as soccer), 3.) Yoga or pilates, and for heart rate and measurement variability. LV volumes, ejection fraction and left atrial 169 volumes were calculated using the modified biplane technique (14). LV mass was 170 calculated using the area-length method and LV geometry was assessed using relative 171 wall thickness. Right ventricular (RV) end-diastolic area, end-systolic area, basal 172 diastolic diameter, diastolic length and fractional area change were measured from RV 173 optimized apical 4-chamber images. LV myocardial tissue velocities were measured in 4 174 basal segments (septum, lateral, inferior and anterior) and RV velocities were measured 175 in the RV free wall base using a modified apical 4-chamber view. LV longitudinal strain 176 was analysed using speckle tracking software (Echopac, GE Medical, Horten, Norway, 177 version 112.1.6) of two dimensional grey-scale images taken from the apical four, two 178 and three chamber views. In order to time-align and adjust for inter-individual variability 179 of heart rate, frame-by-frame data were exported to custom-made software that 180 completed cubic spline interpolation to produce 600 data points for both the systolic and 181 diastolic periods as previously described (29, 30) . All measurements are presented as raw 182 data and after body surface area indexing via the Mosteller formula (17) where 183 appropriate. Values defining the limits of normal right and left ventricular structure were 184 adopted from the American Society of Echocardiography/European Association of 185 Echocardiography chamber quantification recommendations (14) . Intra and inter-186 observer variability data from our laboratory for the key echocardiographic variables 187 reported in this study have been previously published (3). 188 189
Cardiopulmonary exercise testing 190
Exercise tests were conducted on a treadmill (Pro XL, Woodway Inc. WI) using a 191 graded maximal effort-limited protocol with continuous electrocardiography and breath-192 by-breath measurement of metabolic gas exchange. The test protocol consisted of a 2-193 minute period of standing rest to facilitate ventilatory equilibrium after which treadmill 194 speed and gradient were increased to 5 miles.hr -1 (8.0 km.h -1 ) and 1% respectively for 10 195 minutes to facilitate musculoskeletal warm up. After the warm up phase, speed was 196 maintained at 5 miles hr -1 and gradient increased by 0.5% every 15 s until volitional 197 exhaustion. Gas exchange was measured using a commercially available metabolic cart 198 (Ultima CardiO2; Medgraphics, St.Paul, MN). Oxygen consumption (V̇O 2 ) data were 199 smoothed using a 5 breath rolling mean with the highest and lowest values in each 7 200 breaths removed and peak oxygen consumption (V̇O 2 peak) was defined as the highest 5 201 breath mean value during exercise. The ventilatory threshold was determined by the 202 modified V-slope method (6). Heart rate was continuously recorded during exercise 203 using a wireless 12-lead electrocardiogram system (Mortara X12+ Transmitter; Mortara 204
Instruments, WI). Primary outcome variables of exercise were time to exhaustion and 205 V̇O 2 peak. 206 207
Carbon Monoxide Rebreathing 208
Total hemoglobin mass (tHb-mass) and BV were quantified using the optimized 209 carbon monoxide (CO) rebreathing method described in detail by Schmidt and Prommer 210 (26) . In brief, since CO binds avidly to hemoglobin (Hb), carboxyhemoglobin (COHb) 211 concentration was measured in blood after 2 minutes of rebreathing a known CO volume 212
(1.0 ml . kg -1 in males and 0.9 ml . kg -1 in females). Each participant was seated for 15 213 minutes to allow stabilization of plasma volume, after which a mouthpiece containing 214 ~10g 'soda lime' (calcium oxide/sodium hydroxide mixture as a carbon dioxide scrubber) 215 connected them to a custom made spirometer (Spico-CO Respirations-Applikator, Blood 216 Tec, Germany) and a 3 litre anesthetic bag pre-filled with 100% oxygen. The participants 217 were instructed to completely exhale to residual volume and then take a deep breath in 218 through the spirometer while the CO dose was administered into the rebreathing circuit 219 via a pre-filled 100 ml syringe. To support the diffusion of CO into the blood, 220 participants were instructed to perform a 10 second breath hold after the first inspiration, 221 after which they continued normal breathing from the spirometer for 1 min 50 s. The 222 participants were then disconnected from the CO rebreathing circuit after exhaling to 223 residual volume. The exhaled volume was collected and analyzed to quantify the amount 224
CO not bound to hemoglobin. Finally, participants fully exhaled to residual volume into 225 a CO gas analyzer (Drager Pac 7000, Dragerwerk AG & Co. KGaA, Germany) before, 226 and at 4 minutes after CO rebreathing to determine the CO volume exhaled after 227 disconnecting the patient from the spirometer. where: 240 K = barometric pressure x 760 -1 x [1(0.003661 x temperature)] 241 MCO = CO adm -(CO system + lung (after disconnection) + CO exhaled (after disconnection) ) 242 CO adm = CO volume administered into the system 243 CO system + lung (after disconnection) = CO concentration in spirometer x (spirometer volume + 244 lung residual volume) 245 CO exhaled (after disconnection) = end-tidal CO concentration x alveolar ventilation rate 246 Δ%COHb = difference between baseline %COHb and %COHb post CO 247 administration (average of 6-and 8-min %COHb values) 248
1.39 = Hüfners number (constant) (ml CO x g Hb -1 ) 249
Alveolar ventilation rate is assumed to be 5 L.min -1 250 251 Blood volume, plasma volume and erythrocyte volume were calculated from the 252 hematocrit, hemoglobin concentration ([Hb]) and tHb-mass using the following formulae: 253
Plasma volume (ml) = BVerythrocyte volume 256 257 Hematocrit and hemoglobin concentration values were obtained from capillary 258 blood and were corrected to venous conditions using the following formulae (7, 27) was assessed using mixed linear modeling with age, V̇O 2 peak, and gender as fixed effects 271 and subject identification as a random effect. Akaike's information criterion tool was 272 used to select optimal covariance structures for each model. Twenty-one participants (age = 34 ± 7 years, 48% men) completed the 2016 283
Boston Marathon (4:28 ± 0:27 hours:mins) and then adhered to the 8-week detraining 284 protocol ( Table 1) . Running volume decreased from 31.6 ± 9.6 miles.week -1 during the 285 final marathon training phase to 3.4 ± 3.1 miles.week -1 during weeks 0 to 4 weeks and 4.8 286 Hematologic and cardiac structural and functional data across study time points 297 are detailed in Table 2 and Table 3 respectively. After 4-weeks of detraining, BV and 298 plasma volume were both significantly decreased compared to baseline while erythrocyte 299 volume and total hemoglobin mass were unchanged. This was accompanied by 300 Similarly, there were no further reductions in LV wall thickness and LV chamber 312 dimensions remained unchanged. However, there was a significant reduction in RV size 313 as demonstrated by multiple complementary indices including RV length, basal diameter, 314 end-diastolic area, and outflow tract diameter. Aside from the tricuspid annular plane 315 systolic excursion, which was decreased but remained within normal limits, there were no 316 statistically significant changes in LV or RV function in systole or diastole at 8 weeks 317 compared to both previous study time points. 318
No significant correlations were identified between delta PV and delta BV, and 319 delta LV mass or any chamber volume or area delta values at the 8-week time point (R 2 320 values from 0.01-0.13; P values from 0.12-0.95). 321 322 323
DISCUSSION

325
This longitudinal study, designed to examine the cardiovascular response to 326 exercise detraining among recreational marathon runners, generated the following 327 principal findings. Eight weeks of reduced training volume led to a decline in peak 328 treadmill exercise time, significant reductions in BV, and reverse cardiac remodeling. 329
Specifically, we observed a 3.6% decline in BV, which was driven by reductions in 330 plasma volume with concomitant stability of erythrocyte volume and total hemoglobin 331 mass. This relatively rapid hematologic response occurred early during the study period 332
and was completed within 4 weeks. In contrast, differential cardiac remodeling occurred 333 during the two phases of the study period. Specifically, we observed an early and highly 334 significant reduction in LV mass, driven by reductions in wall thickness, followed by a 335 subsequent decline in right ventricle size. Contrary to our a priori hypothesis, 336 hematologic and myocardial changes were not all temporally coupled and associations 337 between Δ PV and echocardiographic measurements were not significant, with the 338 exception of a weak association between Δ PV and Δ EF%. This suggests that reverse 339 cardiac remodeling, specifically reductions in ventricular chamber dimensions, are not 340 mechanistically driven by a simple reduction in BV. In aggregate, these findings provide 341 novel insights into how the cardiovascular system responds to a sudden and marked 342 reduction in exercise exposure. 343
A large body of prior work has delineated the cardiovascular structural and 344 functional plasticity in response to endurance exercise training (4, 11). Specifically, 345 endurance exercise stimulates eccentric remodeling of the left ventricle, right ventricular 346 dilation, biatrial dilation, and an expansion of BV. These adaptations have been 347 demonstrated among numerous populations including recreational or novice exercisers 348 (1, 13, 28, 35) , highly trained and collegiate athletes (23, 33) young elite athletes (18), 349 and aging masters athletes (10). Comparatively, few studies have examined the reverse 350 cardiac remodeling associated with physical deconditioning. Important prior work 351 documents cardiac atrophy during prolonged bed rest, with 60 days of head down tilt bed 352 rest in healthy females (a similar duration to the present study) and a similar 6-week 353 study of horizontal bed rest in males reporting highly significant reduction in LV 354 chamber size (~20%) and LV mass (~8.0%) (9). Similarly, there are several studies 355 examining elite athletes following termination of training and competition (5, 15, 20) , 356 with one report documenting a 7% decrease in LV cavity dimensions and a 15% decrease 357 in LV wall thickness after long term (1-13 years) deconditioning (20). These prior data 358 may represent the upper limits of the reverse remodeling but are not generalizable to the 359 sizable and rapidly growing population of recreationally exercising people. In addition, 360
we are unaware of any prior data defining the temporal sequence, right heart 361 involvement, and role of vascular volume contraction on reverse cardiac remodeling 362 during detraining. Findings from this study address each of these key areas of uncertainty 363 and thereby enhance our understanding of exercise-related cardiac plasticity in several 364 ways. Our findings suggest that 4 weeks of detraining causes a reduction in left 365 ventricular wall thickness and that 8 weeks of detraining are sufficient to observe 366 reductions in right ventricular chamber size. It is noteworthy and perhaps surprising that 367 we did not observe a reduction in left ventricular chamber dimensions. It is possible that 368 our study duration was insufficient to capture left ventricular regression, the preceding 369 training stimulus was not sufficient to cause a significant dilation prior to our detraining 370 study period, or alternatively, that LV chamber dimensions may be less responsive to 371 removal of exercise as has been previously suggested. (20) . 372
Blood volume, particularly the plasma component, expands acutely in response to 373 endurance training (16, 24, 31) or during acclimatization to environmental stimuli (22) . 374
To date, few studies have examined changes in BV during exercise detraining and we are 375 unaware of any work designed to examine the relationship between physiologic BV 376 fluctuation and myocardial structure and function in this context. While biochemical 377 mediators and cellular adaptations underlying exercise-induced cardiac remodeling have 378 been well described (32), the potential role of BV as a physical determinant of cardiac 379 structure and function in this setting has not been rigorously explored. Based on the 380
Frank-Starling mechanism, we hypothesized that a significant percentage of the expected 381 decline in cardiac chamber size would be caused by simple BV or PV contraction. Our 382 data refute this hypothesis and suggest that acute reductions in BV or PV during exercise 383 cessation contribute minimally to reverse cardiac remodeling. While speculative, it is 384 possible that acute contraction of BV during exercise detraining is coupled with a decline 385 in peripheral venous capacitance, which facilitates maintenance of central BV. This 386 speculation is supported by the fact we observed no statistically significant changes 387 across numerous highly preload dependent indices of myocardial function including 388 trans-mitral Doppler velocities. Further research designed to explore this potentially 389 adaptive coupling of the peripheral vasculature with the myocardium represents an 390 important area of future work. Finally, it is noteworthy that the erythrocyte compartment 391 of the blood volume: tHbmass, was not significantly different across study timepoints. 392
The stability of tHbmass parallels our peak V̇O 2 data which also did not significantly 393 decline with detraining as these parameters are well known to be tightly coupled (25) . 394
Given that red cells have a lifespan of approximately 110 days (12), beyond the length of 395 our study, a longer detraining phase may be required to stimulate a reduction in tHbmass. 396
Several limitations of the present study must be acknowledged. First, although 397 our sample size was adequately powered to detect clinically and statistically significant 398 changes in cardiac morphology during exercise detraining, we lack sufficient numbers to 399 investigate fully the impact of gender on our observations. While our mixed model 400 analyses adjusted for gender we cannot exclude the notion that men and women may 401 respond differently to prescribed detraining. Second, our study period was confined to 8 402 weeks and included only 2 detraining study time points. Thus we are unable to comment 403 with any more accuracy than "early" and "late" response regarding the temporal sequence 404 of our observation. More frequent observations over a more extended time period may 405 have yielded a more detailed characterization of the detraining response and should be 406 considered in future similar studies. Third, we employed a detraining protocol involving 407 marked reductions in exercise exposure but not complete abstinence. This choice was a 408 deliberate step to maximize subject recruitment and to make our results generalizable 409 among individuals who do not stop exercising completely, however, this may have 410 resulted in Type 2 error. Fourth, as we previously described exercise-induced cardiac 411 remodeling during marathon training in a similar cohort, we elected not to study our 412 current participants during marathon preparation. We are therefore unable to comment on 413 the completeness of the reverse remodeling we observe during detraining. Finally, our 414 cohort was comprised of recreational marathon runners rather than elite or sub-elite 415 athletes and we are thus unable to comment on how our findings apply to these 416 specialized populations. 417
In conclusion, a sudden and sustained decrease in exercise volume over 8 weeks 418 results in the regression of exercise-induced cardiac remodeling and a reduced plasma 419 volume in recreational marathon runners. This regression follows distinct structure-420 specific 'early' and 'late' time courses characterized by early reductions in LV wall 421 thickness and mass followed by later reductions in RV chamber size. Contrary to our a 422 priori hypothesis, contraction of blood volume does not appear to represent a causal 423 mechanism in the reverse cardiac remodeling during exercise detraining. Values are presented as median (interquartile range); BMI = Body Mass Index; 563 V̇O 2 peak = Peak oxygen uptake. 564 565 P values represent a significant slope across all three measurements. † denotes a highly 568 significant difference from pre-marathon (P<0.01); Vol. = volume; tHbmass = total 569 hemoglobin mass; T Lim = Time to exhaustion; peak = maximal aerobic capacity; 570 peak = maximal ventilation; T VT = time to reach ventilatory threshold; VT = 571 oxygen uptake at the ventilatory threshold. 572 573 P values represent a significant slope across all three measurements. *denotes a 576 significant difference from pre-marathon (P<0.05); † denotes a significant difference 577 from pre-marathon (P<0.01); ‡ denotes a significant difference from 4 weeks post 578 marathon (P<0.05). LVIDd = left ventricular internal dimension (diastole); LV = left 579 ventricular; RWT = relative wall thickness; LVEDV = left ventricular end-diastolic 580 volume; LA = left atrial; S' = peak systolic tissue velocity ; E' = early diastolic peak 581 tissue velocity; A' = late diastolic peak tissue velocity; E-wave = early mitral inflow 582 filling velocity; A-wave = late mitral inflow filling velocity; E/A ratio = ratio of early to 583 late ventricular filling velocities. 584 585 586 Right Heart Structure RV Length, cm 8.4(7.9,8.9) 8.3(7.9,8.8) 8.0(7.6,8.7) † 0.002 RV Basal diameter, cm 3.5(3.2,3.9) 3.5(3.3,3.8) 3.4(3.2,3.7)* 0.03 RVAd, mm 2 18.9(15.1,21.0) 18.6(16.4,21.9) 17.5(16.0,21.8)* 0.01 RVAd / BSA, mm 2 /m 2 10.7(9.5,11.9) 10.9(9.7,11.8) 10.4(9.2,11.4)* ‡ 0.02 RVOT1, cm 3.1(2.7,3.3) 3.0(2.8,3.3) 2.9(2.5,3.0) † ‡ 0.015 RVOT2, cm 2.3(2.0,2.5) 1.9(1.8,2.1) † P values represent a significant slope across all three measurements. *significant 589 difference from pre-marathon (P<0.05); † denotes a significant difference from pre-590 marathon (P<0.01); ‡ denotes a significant difference from 4 weeks post marathon 591 (P<0.05). RV = right ventricular; RVAd = right ventricular area in diastole; RVOT1 = 592 proximal right ventricle outflow tract; RVOT2 = distal right ventricle outflow tract; 593 RVPLAX = parasternal long axis view of the right ventricle; RA = right atrium; RVFAC 594
